MONTREAL, May 29, 2025 (GLOBE NEWSWIRE) — GURU Organic Energy Corp. (TSX: GURU) (“GURU” or the “Company”), Canada’s leading organic energy drink brand1, will report its financial results for the second quarter ended April 30, 2025, on Thursday, June 12, 2025, before markets open. Management will hold a conference call to discuss its financial results the same day at 10:00 a.m. ET. The conference call will include a Q&A period open exclusively to financial analysts who are invited to participate by using the dial-in number provided below. Other interested parties are invited to participate in the call on a listen-only basis and are encouraged to do so via live audio webcast, which will be available on GURU’s website. Conference call and webcast details:Thursday, June 12, 2025, at 10:00 a.m. ET   Via webcast: https://edge.media-server.com/mmc/p/9xbgzdhc   Via...

NEW YORK and WALTHAM, Mass., May 29, 2025 (GLOBE NEWSWIRE) — Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, today announced the Company’s participation in the Jefferies Global Healthcare Conference. Marino Garcia, Chief Executive Officer, will participate in a fireside chat on Thursday, June 5, 2025 at 9:55 a.m. EDT in New York City and will host one-on-one meetings with investors. A live webcast of the Company’s presentation may be accessed under “News and Events” in the Investors section of the Dianthus Therapeutics website. About Dianthus TherapeuticsDianthus Therapeutics is a clinical-stage biotechnology company dedicated to designing and delivering novel, best-in-class monoclonal...

Baker Hughes will supply 16 NovaLT™ gas turbines for data center projects in the U.S. Award builds on the collaboration announced in March 2025 between Baker Hughes and FrontierHOUSTON and LONDON, May 29, 2025 (GLOBE NEWSWIRE) — Baker Hughes (NASDAQ: BKR), an energy technology company, announced Wednesday an award from Frontier Infrastructure Holdings (“Frontier”), a Tailwater Capital LLC portfolio company, for 16 NovaLT™ gas turbines to power its data center projects in Wyoming and Texas, delivering up to 270 megawatts (MW) of efficient, reliable power. As part of the award, Baker Hughes is supplying Frontier its NovaLT™ gas turbine technology and associated equipment, including gears and Brush Power Generation four-pole generators, to power dedicated energy islands at Frontier’s behind-the-meter (BTM)...

EDISON, N.J., May 29, 2025 (GLOBE NEWSWIRE) — Eos Energy Enterprises, Inc. (NASDAQ: EOSE) (“Eos” or the “Company”) today announced its intention to offer, subject to market and other conditions, $175,000,000 aggregate principal amount of convertible senior notes due 2030 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Eos also expects to grant the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $26,250,000 aggregate principal amount of notes. The notes will be senior, unsecured obligations of Eos, will accrue interest payable semi-annually in arrears and will...

EDISON, N.J., May 29, 2025 (GLOBE NEWSWIRE) — Eos Energy Enterprises, Inc. (NASDAQ: EOSE) (“Eos” or the “Company”) today announced that it has commenced a $75,000,000 common stock offering (the “Offering”). The Offering is being made pursuant to the Securities Act of 1933, as amended (the “Securities Act). The Company expects to grant the underwriters of the Offering, a 30-day option to purchase up to an additional $11,250,000 of common stock, at the public offering price, less the underwriting discounts. The Offering is subject to market and other conditions, and there can be no assurance as to whether or when either the Offering may be completed, if at all, or as to the actual size or terms of the Offering. Eos expects to use the net proceeds from the Offering, together with the net proceeds from the offering of the notes referred...

Discontinues Development of Cibotercept in PAH Announces Corporate Restructuring to Align Operations with Ongoing Strategic Priorities LEXINGTON, Mass., May 29, 2025 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”, the “Company” or “we”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (“TGF-ß”) family of proteins, today announced topline data from the TROPOS trial, a Phase 2 clinical trial of cibotercept (KER-012) in combination with background therapy in patients with pulmonary arterial hypertension (“PAH”), and provided a corporate update. TROPOS Trial Results TROPOS is a randomized, double-blind, placebo-controlled, global...

JERICHO, N.Y., May 29, 2025 (GLOBE NEWSWIRE) — Kimco Realty® (NYSE: KIM) announced today that members of its management team will present at the Nareit REITweek Investor Conference on Wednesday, June 4, 2025. The webcast information is as follows: When: Wednesday, June 4, 2025 from 9:30 AM – 10:00 AM, ET Live Webcast: Kimco Realty Presentation Link, or enter https://vimeo.com/event/5090222/ into your browser. Audio from the conference will be available on Kimco Realty’s investor relations website until July 5, 2025.   About Kimco Realty®Kimco Realty® (NYSE: KIM) is a real estate investment trust (REIT) and leading owner and operator of high-quality, open-air, grocery-anchored shopping centers and mixed-use properties in the United States. The company’s portfolio is strategically concentrated in the first-ring suburbs of the top...